These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 19553817)

  • 1. Predicting life expectancy in prostate cancer patients.
    Jeldres C; Latouff JB; Saad F
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):166-9. PubMed ID: 19553817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer.
    Walz J; Gallina A; Perrotte P; Jeldres C; Trinh QD; Hutterer GC; Traumann M; Ramirez A; Shariat SF; McCormack M; Perreault JP; Bénard F; Valiquette L; Saad F; Karakiewicz PI
    BJU Int; 2007 Dec; 100(6):1254-8. PubMed ID: 17979925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer.
    Walz J; Gallina A; Hutterer G; Perrotte P; Shariat SF; Graefen M; McCormack M; Bénard F; Valiquette L; Saad F; Karakiewicz PI
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):88-94. PubMed ID: 17446004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting life expectancy in men with clinically localized prostate cancer.
    Cowen ME; Halasyamani LK; Kattan MW
    J Urol; 2006 Jan; 175(1):99-103. PubMed ID: 16406881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inventory of prostate cancer predictive tools.
    Shariat SF; Karakiewicz PI; Margulis V; Kattan MW
    Curr Opin Urol; 2008 May; 18(3):279-96. PubMed ID: 18382238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of life tables in predicting overall survival in patients after radical prostatectomy.
    Walz J; Suardi N; Shariat SF; Jeldres C; Perrotte P; Graefen M; Widmer H; Arjane P; Valiquette L; Hutterer G; Saad F; Karakiewicz PI
    BJU Int; 2008 Jul; 102(1):33-8. PubMed ID: 18384631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature.
    Shariat SF; Karakiewicz PI; Suardi N; Kattan MW
    Clin Cancer Res; 2008 Jul; 14(14):4400-7. PubMed ID: 18628454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a prostate cancer metagram: a solution to the dilemma of which prediction tool to use in patient counseling.
    Nguyen CT; Kattan MW
    Cancer; 2009 Jul; 115(13 Suppl):3039-45. PubMed ID: 19544545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a clinical prediction model to calculate patient life expectancy: the measure of actuarial life expectancy (MALE).
    Clarke MG; Kennedy KP; MacDonagh RP
    Med Decis Making; 2009; 29(2):239-46. PubMed ID: 19047762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer.
    Hall WH; Jani AB; Ryu JK; Narayan S; Vijayakumar S
    Prostate Cancer Prostatic Dis; 2005; 8(1):22-30. PubMed ID: 15700051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An updated catalog of prostate cancer predictive tools.
    Shariat SF; Karakiewicz PI; Roehrborn CG; Kattan MW
    Cancer; 2008 Dec; 113(11):3075-99. PubMed ID: 18823041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The assessment of patient life-expectancy: how accurate are urologists and oncologists?
    Wilson JR; Clarke MG; Ewings P; Graham JD; MacDonagh R
    BJU Int; 2005 Apr; 95(6):794-8. PubMed ID: 15794785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Life Expectancy in Men Diagnosed with Prostate Cancer.
    Sammon JD; Abdollah F; D'Amico A; Gettman M; Haese A; Suardi N; Vickers A; Trinh QD
    Eur Urol; 2015 Nov; 68(5):756-65. PubMed ID: 25819724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and statistical methods in prediction of patient outcome.
    Bostwick DG; Adolfsson J; Burke HB; Damber JE; Huland H; Pavone-Macaluso M; Waters DJ
    Scand J Urol Nephrol Suppl; 2005 May; (216):94-110. PubMed ID: 16019761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current state of brachytherapy nomograms for patients with clinically localized prostate cancer.
    Nguyen CT; Zelefsky MJ; Kattan MW
    Cancer; 2009 Jul; 115(13 Suppl):3121-7. PubMed ID: 19544540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of localized prostate cancer in senior adults: the crucial role of comorbidity.
    Fitzpatrick JM
    BJU Int; 2008 Mar; 101 Suppl 2():16-22. PubMed ID: 18307688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting cancer-control outcomes in patients with renal cell carcinoma.
    Isbarn H; Karakiewicz PI
    Curr Opin Urol; 2009 May; 19(3):247-57. PubMed ID: 19325492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive models of toxicity with external radiotherapy for prostate cancer: clinical issues.
    Valdagni R; Rancati T; Fiorino C
    Cancer; 2009 Jul; 115(13 Suppl):3141-9. PubMed ID: 19544543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer nomograms: an update.
    Chun FK; Karakiewicz PI; Briganti A; Gallina A; Kattan MW; Montorsi F; Huland H; Graefen M
    Eur Urol; 2006 Nov; 50(5):914-26; discussion 926. PubMed ID: 16935414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based medicine in prostate cancer: where do we stand in 2006?
    Dahm P
    Curr Opin Urol; 2006 May; 16(3):162-7. PubMed ID: 16679853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.